Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Christina V. Malichewe"'
Autor:
Mercy M. Mbai, Emmanuel Mduma, Samuel Thuo, Eulade Rugengamanzi, Christina V. Malichewe, Emmanuel L. Lugina
Publikováno v:
BMC Cancer, Vol 24, Iss 1, Pp 1-11 (2024)
Abstract Background The incidence of Hodgkin's lymphoma (HL) in people living with HIV (PLWHA) and on HAART is approximately 20–30 times higher than in HIV-negative individuals. Most patients with HIV-HL present at an advanced stage (III-IV) have '
Externí odkaz:
https://doaj.org/article/2465cd3d3f4c4f40acd2e81ca42c7627
Autor:
Lulu Lunogelo Sakafu, Godfrey Sama Philipo, Christina V. Malichewe, Lulu S. Fundikira, Flora A. Lwakatare, Katherine Van Loon, Beatrice P. Mushi, Rebecca J. DeBoer, Stella A. Bialous, Amie Y. Lee
Publikováno v:
PLoS ONE, Vol 17, Iss 10 (2022)
Background Women with breast cancer in sub-Saharan Africa are commonly diagnosed at advanced stages. In Tanzania, more than 80% of women are diagnosed with stage III or IV disease, and mortality rates are high. This study explored factors contributin
Externí odkaz:
https://doaj.org/article/d30285d815214a60b5da84cb2eb2f1ee
Autor:
Lulu Lunogelo Sakafu, Godfrey Sama Philipo, Christina V. Malichewe, Lulu S. Fundikira, Flora A. Lwakatare, Katherine Van Loon, Beatrice P. Mushi, Rebecca J. DeBoer, Stella A. Bialous, Amie Y. Lee
Publikováno v:
PloS one, vol 17, iss 10
Background Women with breast cancer in sub-Saharan Africa are commonly diagnosed at advanced stages. In Tanzania, more than 80% of women are diagnosed with stage III or IV disease, and mortality rates are high. This study explored factors contributin
Autor:
Zhenning Lu, Xiaoxia Yang, Yongfang Zhang, Lei Wang, Christina V. Malichewe, Xiu-Li Guo, Zhao-Yu Shi
Publikováno v:
Journal of Drug Delivery Science and Technology. 52:1061-1069
MicroRNA34a is a tumor suppressor microRNA which is significantly down-regulated in breast cancer cells such as MDA-MB-231 cell and has been reported to be used as a therapeutic target for breast cancer. However, the delivery of miRNAs has always bee
Autor:
Chunqian Zhao, Lei Wang, Xinke Zhang, Christina V. Malichewe, Xiu-Li Guo, Lin Zhao, Hongyuan Chen, Lu Lu
Publikováno v:
Life Sciences. 270:119113
Aims This study aimed to design and screen a dual functional fusion peptide that could penetrate the blood-brain barrier and target neuropilin 1 (NRP1) overexpressed in vascular endothelial cells for the anti-angiogenesis of glioma treatment. Main me